Biography
Maryam is a PharmD (Doctor of Pharmacy) and PhD in medicine, with more than 15 years of research experience in natural or synthetic anti-cancer drug development. In 2020, she was awarded the prestigious "Vice-chancellor Alfred Deakin Research Fellowship" at Deakin University to develop the novel immunotherapy nanomedicines, aptamers, for the treatment of triple-negative breast cancer brain metastasis.
She has been an organising member of several international pharmaceutical conferences. She has been the guest editor of several Q1 special issues, including "Potential Molecular Targets and Therapeutics in Triple-Negative Breast Cancer" at "Pharmaceuticals, IF: 5.68" journal, "Drug delivery to brain tumours" at "Journal of Personalised Medicine, IF: 4.94" and "Anticancer drugs" at "Frontiers in Bioscience-Landmark, IF: 3.81".
Read more on Maryam's profileResearch interests
Anti-cancer drug development
Drug development for brain tumours
Pharmacology and toxicology of anticacner drugs
Affiliations
- School of Medicine, Faculty of Health, Deakin University, 75 Pigdons Road, Waurn Ponds VIC 3216 Australia
- Institute for Mental and Physical Health and Clinical Translation,
Knowledge areas
Anti-cancer drug development
Pharmacology and toxicology
Conferences
- Ginsenoside Rg3 enantiomers in a defined ratio as a novel treatment for metastatic triple negative breast cancer in San Antonio Breast Cancer Symposium (Virtual). 2020. Texas, USA.
- Ginsenoside Rg3 enantiomers in a defined ratio as a novel treatment for triple negative breast cancer in TQEH Research Day 2020. 2020. SA, Australia.
- Ginsenoside Rg3, a potential novel treatment for metastatic breast cancer. in Florey's Postgrad Seminar. 2020. SA, Australia.
- Novel candidates for the treatment of metastatic breast cancer. in Adelaide Pharmacology Group (APG) Meeting. 2019. Adelaide.
- Comparison of the molecular modelling of bacopaside I and bacopaside II, candidate anti-angiogenic agents, with sorafenib. in ASMR SA Scientific Meeting. 2018. SA, Australia.
- Ginsenoside Rg3; an anti-invasion candidate for triple negative breast cancer. in Florey's Postgrad Seminar. 2018.
- 20(S)-ginsenoside Rg3; an anti-invasive candidate for triple negative breast cancer in TQEH Research Expo. 2018. SA, Australia.
- Breast Cancer Cells Reaction to Serum Starvation and Steroid Restriction. in The 10th International Breast Cancer. . 2015. Tehran, Iran.
- FTIR recognition of cell damage following serum starvation. in The 12th Iranian Congress of Toxicology. 2013. Sari, Iran.
- Methyl Paraben induces proliferation andencounters with Tamoxifen in human ovarian adenocarcinoma cell line. in The 12th Iranian Congress of Toxicology. 2013. Sari, Iran.
- Studying silibinin effect on human endothelial and hepatocarcinoma cell lines. in The 13th International Iranian Pharmaceutical Sciences Congress. 2012. Isfahan, Iran.
- Lidocaine as a potential antagonist for Odontobuthos Doriae scorpion venom in mice. in The 13th International Iranian Pharmaceutical Sciences Congress. 2012. Isfahan, Iran.
- Studying the effect of methylparaben and propylparaben on growth curve of human breast adenocarcinoma cell line. in The 13th International Iranian Pharmaceutical Sciences Congress. 2012. Isfahan, Iran.
- Nakhjavani, M. in Globalize this: Health. 2011. Trondheim, Norway: International Student Festival in Trondheim.
- Technological advancements and future society. in The 22nd International Youth Forum. 2011. Seoul, South Korea.
- Counterfeit drugs in EMRO countries. in The 12th international pharmaceutical sciences congress. 2010. Zanjan, Iran.
- Cytotoxicity of novel 1,3-diarylprop-2-en-1-one derivatives on human hepato, breast and lung carcinoma cells. in Physiology Pharmacologey Congress. 2009. Tehran, Iran: (Awarded for the top 3 oral presentations by the scientific committee of the congress).
- Specific considerations in using MTT assay. in The 11th international pharmaceutical sciences congress. 2008. Kerman, Iran: (Awarded for the best oral presentation by the scientific committee of the congress).
- Cytotoxicity of three novel 1,3-diarylprop-2-en-1-one derivatives on human hepato and epithelial carcinoma cells. in The 11th international pharmaceutical sciences congress. 2008. Kerman, Iran.
- Application of ANN models in prediction of antidepressant demand in Iran. in The 11th international pharmaceutical sciences congress. 2008. Kerman, Iran.
- Application of ANN models in prediction of antidepressant dosage forms demand in Iran. in The 21st international medical sciences student congress. 2008. Istanbul, Turkey.
Media appearances
https://www.basilhetzelinstitute.com.au/dr-maryam-nakhjavani-awarded-a-deans-commendation-and-an-alfred-deakin-postdoctoral-fellowship/
https://www.schoolandcollegelistings.com/AU/Woodville/321219921227571/Basil-Hetzel-Institute-for-Translational-Health-Research
Awards
- Alfred Deakin Postdoctoral Research Fellowship, 2021 (191,418 AUD)
- Dean’s Commendation for Doctoral Thesis Excellence, 2021.
- Innovation and Commercial Partners Prize, Florey's Postgraduate Conference 2020
- The Doctor Chun Chung Wong and Madam So Sau Lam Memorial Postgraduate Cancer Research Top-Up Scholarship, 7000 AUD (2019)
- Invited as one of the 50 women of impact and influence, University of Adelaide (2019)
- Best mini-oral presentation, TQEH Research Expo, Adelaide (2019)
- Awarded Adelaide Scholarship International (ASI) (International Wildcard Scholarship), 98000 AUD (2018)
Publications
Cytotoxic effects of aptamer-doxorubicin conjugates in an ovarian cancer cell line
J Henri, M Nakhjavani, S McCoombe, S Shigdar
(2023), Vol. 204, pp. 108-117, Biochimie, France, C1
Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
M Nakhjavani, S Shigdar
(2022), Vol. 175, pp. 1-11, Pharmacological Research, Amsterdam, The Netherlands, C1
M Nakhjavani, R Samarasinghe, S Shigdar
(2022), Vol. 27, pp. 1298-1314, Drug Discovery Today, Amsterdam, The Netherlands, C1
Mohsen Sarafraz, Maryam Nakhjavani, Sarah Shigdar, Farid Christo, Bernard Rolfe
(2022), Vol. 173, pp. 121-131, European Journal of Pharmaceutics and Biopharmaceutics, Amsterdam, The Netherlands, C1
M Nakhjavani, S Shigdar
(2022), Vol. 14, Cancers, Switzerland, C1
M Nakhjavani, E Smith, K Yeo, H Palethorpe, Y Tomita, T Price, A Townsend, J Hardingham
(2021), Vol. 13, Cancers, Switzerland, C1
M Nakhjavani, E Smith, H Palethorpe, Y Tomita, K Yeo, T Price, A Townsend, J Hardingham
(2021), Vol. 14, pp. 1-20, Pharmaceuticals, Basel, Switzerland, C1
Y Tomita, E Smith, H Palethorpe, M Nakhjavani, K Yeo, A Townsend, T Price, A Yool, J Hardingham
(2021), Vol. 14, pp. 1-18, Pharmaceuticals, Basel, Switzerland, C1
Differential antiangiogenic and anticancer activities of the active metabolites of ginsenoside Rg3
M Nakhjavani, E Smith, K Yeo, Y Tomita, T Price, A Yool, A Townsend, J Hardingham
(2021), pp. 1-10, Journal of Ginseng Research, Amsterdam, The Netherlands, C1
Anti-Angiogenic Properties of Ginsenoside Rg3
M Nakhjavani, E Smith, A Townsend, T Price, J Hardingham
(2020), Vol. 25, Molecules (Basel, Switzerland), Switzerland, C1
Druggable molecular targets for the treatment of triple negative breast cancer
M Nakhjavani, J Hardingham, H Palethorpe, T Price, A Townsend
(2019), Vol. 22, pp. 341-361, Journal of Breast Cancer, Korea (South), C1
E Smith, Y Tomita, H Palethorpe, S Howell, M Nakhjavani, A Townsend, T Price, J Young, J Hardingham
(2019), Vol. 14, pp. 158-170, Epigenetics, Abingdon, Eng., C1
H Palethorpe, E Smith, Y Tomita, M Nakhjavani, A Yool, T Price, J Young, A Townsend, J Hardingham
(2019), Vol. 24, pp. 1-16, Molecules, Basel, Switzerland, C1
Y Tomita, H Palethorpe, E Smith, M Nakhjavani, A Townsend, T Price, A Yool, J Hardingham
(2019), Vol. 20, International Journal of Molecular Sciences, Switzerland, C1
Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer
Maryam Nakhjavani, Jennifer Hardingham, Helen Palethorpe, Yoko Tomita, Eric Smith, Tim Price, Amanda Townsend
(2019), Vol. 6, pp. 1-20, Medicines, Basel, Switzerland, C1
M Nakhjavani, H Palethorpe, Y Tomita, E Smith, T Price, A Yool, J Pei, A Townsend, J Hardingham
(2019), Vol. 12, pp. 1-14, Pharmaceuticals, Basel, Switzerland, C1
Reporting evidence of resistance against severe metabolic stress in human lung carcinoma
M Nakhjavani, F Shirazi
(2019), Vol. 44, pp. 89-99, Fabad Journal of Pharmaceutical Sciences, C1
M Sarafraz, V Nikkhah, M Nakhjavani, A Arya
(2018), Vol. 91, pp. 509-519, Experimental Thermal and Fluid Science, Amsterdam, The Netherlands, C1-1
N Vakili Zahir, M Nakhjavani, P Hajian, F Shirazi, H Mirzaei
(2018), Vol. 17, pp. 261-267, Iranian Journal of Pharmaceutical Research, Netherlands, C1
Long-term effects of metabolic stress on human malignant melanoma cell line
M Nakhjavani, F Shirazi
(2018), Vol. 52, pp. 602-609, Indian Journal of Pharmaceutical Education and Research, Karnataka, India, C1
Reporting long-term effects of metabolic stress on human ovary carcinoma
M Nakhjavani, F Shirazi
(2018), Vol. 22, pp. 152-162, Marmara Pharmaceutical Journal, Istanbul, Turkey, C1
M Sarafraz, V Nikkhah, M Nakhjavani, A Arya
(2017), Vol. 123, pp. 29-39, Applied Thermal Engineering, Amsterdam, The Netherlands, C1-1
M Nakhjavani, V Nikkhah, M Sarafraz, S Shoja, M Sarafraz
(2017), Vol. 53, pp. 3201-3209, Heat and Mass Transfer/Waerme- und Stoffuebertragung, C1-1
N Nikounezhad, M Nakhjavani, F Shirazi
(2017), Vol. 12, pp. 1-7, Journal of Experimental Therapeutics and Oncology, Philadelphia, Pa., C1
How Human Lung Adenocarcinoma Cells React Towards Long-term Metabolic Stress; A Follow Up
Maryam Nakhjavani, Farshad Shirazi
(2017), Vol. 51, pp. S667-S674, INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, C1
Reporting the effect of cell seeding density on growth pattern of cancer cell lines
M Nakhjavani, F Shirazi
(2017), Vol. 13, pp. 87-94, Iranian Journal of Pharmaceutical Sciences, Tehran, Iran, C1
Effect of steroid and serum starvation on a human breast cancer adenocarcinoma cell line
M Nakhjavani, D Stewart, F Shirazi
(2017), Vol. 12, pp. 25-34, Journal of Experimental Therapeutics and Oncology, Philadelphia, Pa., C1
K Ebrahim, H Vatanpour, A Zare, F Shirazi, M Nakhjavani
(2016), Vol. 15, pp. 101-112, Iranian Journal of Pharmaceutical Research, Tehran, Islamic Republic of Iran, C1
Human lung carcinoma reaction against metabolic serum deficiency stress
M Nakhjavani, N Nikounezhad, A Ashtarinezhad, F Shirazi
(2016), Vol. 15, pp. 817-823, Iranian Journal of Pharmaceutical Research, Netherlands, C1
Generation of Cisplatin-resistant ovarian cancer cell lines
N Nikounezhad, M Nakhjavani, F Shirazi
(2016), Vol. 12, pp. 11-20, Iranian Journal of Pharmaceutical Sciences, Tehran, Iran, C1
In Vivo effect of Lidocaine on mouse exposed to Odontobuthos Doriae Scorpion venom
Maryam Nakhjavani, Hossein Vatanpour, Akram Abootorabi, Fatemeh Shahriari, Baharak Mohamadzadehasl, Tannaz Bovand, Saba Vatanpour
(2016), Vol. 5, pp. 368-375, International Journal of Medical Research & Health Sciences, Malviya Nagar, India, C1
Funded Projects at Deakin
No Funded Projects at Deakin found
Supervisions
No completed student supervisions to report